LONDON: SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, announced the acquisition of the entire share capital of Bio-Tech Solutions Ltd (BTS) for a total enterprise consideration of £1.25m payable in cash on closing. BTS is the second acquisition of the Group’s M&A strategy and brings the capabilities of manufacturing and…